Interventional Clinical Trial in Patients in Overactive Bladder With Nocturia in Women

Condition:   Overactive BladderInterventions:   Drug: Tolterodine tartrate extended release capsules + Placebo orally disintegrating tablets;   Drug: Tolterodine tartrate extended release capsules + Desmopressin orally disintegrating tabletsSponsor:   Ferring PharmaceuticalsActive, not recruiting - verified October 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials